Seiler K U, Wassermann O
Naunyn Schmiedebergs Arch Pharmacol. 1975;288(2-3):261-8. doi: 10.1007/BF00500531.
In three species chronic treatment with the anorectic drug chlorphentermine causes a profound alteration of the phospholipid/lipid metabolism in the organism, resulting in an increase of the fractions of phospholipids and lipids, e.g. in lungs, livers and adrenals. The results are interpreted as drug-induced generalized phospholipidosis, which is caused by amphiphilic drugs, like chlorphentermine and others. Its extent depends on several factors, like content, pattern and turnover rate of phospholipids in different organs, and on the species.
在三种物种中,使用食欲抑制药物氯苯丁胺进行长期治疗会导致机体磷脂/脂质代谢发生深刻改变,从而使磷脂和脂质的组分增加,例如在肺、肝脏和肾上腺中。这些结果被解释为药物诱导的全身性磷脂沉积症,它是由两亲性药物如氯苯丁胺等引起的。其程度取决于几个因素,如不同器官中磷脂的含量、模式和周转率,以及物种。